Calendar

Cloudflare’s reported Q2 2026 revenue growth and a $736.8M Q3 revenue consensus provide a credible business backdrop, but the stock fell sharply into the event: it lost roughly 15.5% from Oct. 26 to Oct. 30, including a high-volume down day. Required positive tape and estimate-upside signals are not supported.

ABNB has a small positive whisper-versus-consensus gap and recent company guidance describes strong revenue growth, but the guidance midpoint is slightly below the checked revenue consensus. The stock fell about 4.4% over five sessions, had no close above the 0.75 close-location threshold in the latest three sessions, and no confirmed 1.5x volume session; it does not qualify despite a supportive XLY tape.

EOG has upward EPS estimate revisions, a credible Q3 consensus, and a strong Oct. 30 close, but available checks did not establish positive revenue revisions or a recent >1.5x-volume accumulation day. The company has scheduled its Q3 results for Nov. 5 after close; its IR page separately lists a Nov. 6 results call.

Lumentum's September-quarter EPS estimate rose from $4.21 to $4.22 over the last month, and its prior company guidance midpoint for $1.25B revenue is in line with reported consensus; management cited accelerating AI-driven optical demand and the stock advanced sharply over the preceding five sessions. However, the late-week reversal and lack of a verified normal-volume comparator temper the setup, while valuation and execution risks remain material.

Simon has positive, though non-uniform, estimate momentum: checked consensus showed EPS up 1.74% and revenue up 3.69% over three months, and its latest reported quarter showed 96.0% occupancy, higher retailer sales, and raised full-year FFO guidance. The stock gained about 2.4% over five sessions and closed near the top of its Oct 30 range, but a normal-volume comparison was unavailable and its recent earnings history is uneven.

DVN has positive near-term estimate revisions, rising revenue expectations, four recent EPS beats per Zacks, and an official Nov. 5 reporting date; the stock also strengthened into the event. However, earnings-whisper EPS is below some consensus figures and the shares lagged the energy sector over the past month, while commodity exposure and transaction execution leave meaningful uncertainty.

Earnings Whispers reports a $1.48 whisper against $1.39 consensus, while the prior quarter had strong reported growth; however, no reliable pre-event revenue-revision, verified close-location, or volume-accumulation evidence was found for this screen, and the supplied latest close does not establish recent strength. The positive whisper alone is insufficient for qualification.

ED's reported date and consensus figures were available, and the recent close rose with XLU supportive; Con Edison had reaffirmed its 2026 adjusted EPS guidance. But no positive EPS revision, ESP, whisper, or revenue-upside signal was verified, and none of the last three checked sessions closed in the upper quarter of its range.

A pre-event Zacks article says the estimate-revision combination points toward a likely EPS beat, and recent annualized recovery expectations offer a possible cyclical catalyst. However, exact revision and current-quarter revenue consensus/upside evidence was not verifiable in the checked results, while Oct. 30 brought a high-volume 4.66% selloff and a weak close; it fails the required tape confirmation.

Live Nation has strong operating indicators ahead of the report: the latest available filing said 2026 event ticket sales were pacing 11% higher and deferred revenue reached a second-quarter record, while the stock recovered into Oct. 30 on a large-volume up day. But current-quarter revenue consensus estimates varied across checked providers and no positive EPS revision/ESP/whisper was verified; score remains below the required threshold.

The supplied Nov. 5 date conflicts with checked earnings sources: Earnings Whispers and MarketBeat indicate Nov. 4, while another estimate page shows Nov. 5 and cautions the date may move. Consensus estimates exist, but no positive revisions or required tape confirmation were established; reject on unconfirmed event date and incomplete signals.

MRNA has a modestly favorable EPS revision snapshot and a recent high-volume rebound, but the checked calendar sources describe Nov. 6 as estimated rather than company-confirmed, and no positive revenue revision or upside indicator was verified. The Oct. 22 melanoma-trial data leak coincided with a 17.57% drop and unusually high volume, leaving a volatile, event-driven tape.

Record Q2 fundraising and 20% fee-related-earnings growth, alongside a rising recent share price and several analyst target cuts, create a constructive but mixed backdrop. The checked sources support EPS and revenue consensus, but do not establish positive estimate revisions or an upside surprise signal; recent volume also falls short of a verified accumulation trigger.

Humana's primary IR estimate table showed near-flat Q3 EPS revisions and a credible consensus source provides EPS and revenue estimates, but the stock weakened into the event and underperformed the rising XLV. Medical-cost and Medicare policy uncertainty remain material, while recent tape did not confirm accumulation.

Vistra has a company-confirmed Nov. 6 report date and a strongly positive 30-day Q3 EPS revision, alongside long-term power-demand catalysts. However, shares declined about 5.4% from Oct. 26 through Oct. 30, recent closes were weak in their daily ranges, and the latest quarter missed consensus materially. Positive revisions alone do not offset the poor pre-event tape and limited recent execution evidence.

The prior April buy thesis relied on a Kloeckner closing that has since occurred; the current question is integration economics, not deal completion. Early coverage frames adjusted EPS as a miss and reported a modest after-hours decline, but its timing description is inconsistent, so a settled post-release price reaction is not yet established. No verified analyst revisions or call transcript were available for this early T+1 review. [Company earnings release](https://ir.worthingtonsteel.com/news/news-details/2026/Worthington-Steel-Reports-First-Quarter-Fiscal-2027-Results/default.aspx) [Investing.com](https://www.investing.com/news/earnings/worthington-steel-falls-short-on-q1-earnings-estimates-shares-edge-lower-4935250)

The October 6 close of $98.31 was 3.16% above the prior $95.30 close, so the initial post-earnings reaction was positive despite mixed premarket reports. [StockInvest price history](https://stockinvest.us/stock/RPM) Verified post-print analyst revisions and a sustained T+1 market reaction are not yet available. Sentiment fields set to zero denote unavailable measurements, not neutral observations. The positive deterministic prior is tempered by narrowed guidance and CPG weakness.

The post-print tone is mixed to negative: STZ fell about 4.5% after hours on October 6 despite the quarterly beat, with coverage focusing on unchanged guidance and weak beer depletions. That is an initial reaction, not a confirmed full-session move. Broad post-print analyst revisions, reliable social coverage, options skew, short interest and employee sentiment are unavailable; zeroes in the sentiment fields denote unavailable data, not measured neutrality. [After-hours reaction](https://www.tipranks.com/news/why-did-constellation-brands-stock-fall-over-4-in-after-hours-trading-on-october-6)

The company confirmed a beat versus its expectations and raised guidance; AP reported that shares rallied 7.5% on October 6. [SEC-filed earnings release](https://www.sec.gov/Archives/edgar/data/1679273/000167927326000051/lw-20260830x8kxexx9911q27.htm) [#SEC-8K-2026-10-06]; [AP market report](https://apnews.com/article/stocks-markets-oil-bonds-us-e8285ec7afbe81e9df277e8ee2127982). No reliable post-print analyst revisions were verified for this early T+1 follow-up. Numeric sentiment fields set to zero denote unavailable measurements, not neutral readings; social coverage is insufficient.

Initial coverage linked an approximately 4.25% post-release share rise to the beat and raised outlook. That is an immediate reaction, not evidence the gain held. News tone is positive, but post-print analyst revisions and reliable social, options, short-interest and employee-review measures were unavailable at the research cutoff; the zero sentiment fields denote unavailable data, not neutral readings. [Initial market coverage](https://www.investing.com/news/earnings/penguin-solutions-rises-4-on-strong-q4-beat-raised-outlook-93CH-4935271).

The stock fell 4.87% on the October 1 release day, then recovered to $45.54 by October 5, still below its $46.40 September 30 close; the full move cannot be causally attributed to earnings. Two confirmed October 2 target cuts contrast with the reported consensus beat. News tone is mixed, and verified forward-estimate revisions are unavailable. Social, options, short-interest and employee measures are unavailable; the zero entries are placeholders, not measured neutrality. [Price history](https://stockanalysis.com/stocks/mkc/history/) [Target revisions](https://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62137909/mccormick-analysts-slash-their-forecasts-after-q3-results)

76 , 015 Shares in POET Technologies Inc . $POET Acquired by SummitTX Capital L . P .